Pathway analysis revealed that the following pathways were strongly suggested to be altered in the CRC group: P53-signaling pathway (p-value = 1.28 × 10−08), Wnt signaling pathway (p = 0.0028), Angiogenesis (p-value = 0.00116), EGF-receptor (p-value = 0.0012), TGF-beta signaling (p-value = 0.0021), and Interleukin signaling (p-value = 0.0025). The gene discussed is TP53; the disease is colorectal carcinoma.